PATENT CLAIM ANALYSIS

Application Number: 15741981
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["424", "187100"]

Abstract:
Creation of HIV-1 vaccine immunogens based on glycopeptide scaffolds containing sequences from the V1/V2/V3 and C3 domains of HIV-1 gp120 that is able to bind multiple broadly neutralizing antibodies when expressed in mammalian cells that incorporate mannose-5 and mannose-9 glycans.

Claim (Index 4):
The vaccine immunogen of  claim 1  further comprising N-linked glycosylation sites at positions 160, N301 and N332, and lacking the N156 glycosylation site, able to bind PG9.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.10811
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15635064', '14427393', '15695753', '14363131', '14784501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7301175399804354
- 35 USC 102 Novelty (BERT): 0.5871715002813546
- Combined Prediction Score: 0.7158229360105274
- Mean Citation Score: 433.10390000000007
- Max Citation Score: 579.71185
- Similarity Product: 378.5832455401034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test